Thermo Fisher Scientific Inc.
TMO · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $42,879 | $42,857 | $44,915 | $39,211 |
| % Growth | 0.1% | -4.6% | 14.5% | – |
| Cost of Goods Sold | $25,151 | $25,663 | $25,904 | $19,577 |
| Gross Profit | $17,728 | $17,194 | $19,011 | $19,634 |
| % Margin | 41.3% | 40.1% | 42.3% | 50.1% |
| R&D Expenses | $1,390 | $1,337 | $1,471 | $1,406 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $8,676 | $8,411 | $9,015 | $7,910 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $10,066 | $9,748 | $10,486 | $9,316 |
| Operating Income | $7,662 | $7,446 | $8,525 | $10,318 |
| % Margin | 17.9% | 17.4% | 19% | 26.3% |
| Other Income/Exp. Net | -$667 | -$1,207 | -$862 | -$1,481 |
| Pre-Tax Income | $6,995 | $6,239 | $7,663 | $8,837 |
| Tax Expense | $657 | $284 | $703 | $1,109 |
| Net Income | $6,335 | $5,995 | $6,950 | $7,725 |
| % Margin | 14.8% | 14% | 15.5% | 19.7% |
| EPS | 16.58 | 15.53 | 17.73 | 19.61 |
| % Growth | 6.8% | -12.4% | -9.6% | – |
| EPS Diluted | 16.53 | 15.45 | 17.64 | 19.46 |
| Weighted Avg Shares Out | 382 | 386 | 392 | 394 |
| Weighted Avg Shares Out Dil | 383 | 388 | 394 | 397 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1,078 | $879 | $272 | $43 |
| Interest Expense | $1,654 | $1,491 | $726 | $536 |
| Depreciation & Amortization | $3,108 | $3,406 | $3,381 | $2,592 |
| EBITDA | $11,800 | $11,195 | $11,942 | $11,969 |
| % Margin | 27.5% | 26.1% | 26.6% | 30.5% |